RHEUMATOLOGY

Evaluation of cancer risks in IIM: A Hong Kong perspective on IMACS stratification

30 Oct 2024

The expanding role of musculoskeletal ultrasound in gout diagnosis and management in Hong Kong

16 Jul 2024

Exploring the association of systemic glucocorticoids and incident major adverse cardiovascular events in patients with rheumatoid arthritis based on real-world data

03 Jan 2024

Insights into The Hong Kong Society of Rheumatology's local consensus recommendations for gout management

05 Jul 2023

A local case sharing: Romosozumab as a novel bone-forming alternative in postmenopausal women with osteoporosis

13 Jan 2022

Breaking the myths: Consensus statements from local rheumatologists recommend covid-19 vaccination in patients with autoimmune rheumatic diseases

30 Jul 2021
Expert Insight View All

Evaluation of cancer risks in IIM: A Hong Kong perspective on IMACS stratification

Idiopathic inflammatory myopathies (IIM) is a group of autoimmune disorders characterized by chronic muscle inflammation, presenting with varying clinical features, treatment responses, and prognoses.1 Recently, the International Myositis Assessment and Clinical Studies Group (IMACS) released a set
30 Oct 2024
thumb

Dr. So, Ho

Assistant Professor,
Division of Rheumatology,
Department of Medicine and Therapeutics,
Faculty of Medicine,
The Chinese University of Hong Kong
thumb

Dr. Tang, Yan-Ki Iris

Clinical Assistant Professor of Practice, 
Department of Medicine, 
Li Ka Shing Faculty of Medicine, 
The University of Hong Kong 
Conference update View All
thumb

EULAR 2024

June 12-15, 2024 | Vienna, Austria

Meeting Highlight View All

Shaping romosozumab treatment for postmenopausal osteoporosis: Balancing the fracture benefit and cardiovascular risk

RHEUMATOLOGY
05 May 2021
thumb

Professor Gaetano De Ferrari

Full Professor of Cardiology,
University of Torino,
Head of Cardiology, Città della Salute,
Torino, Italy
Research spotlight View All

Exploring the association of systemic glucocorticoids and incident major adverse cardiovascular events in patients with rheumatoid arthritis based on real-world data

Despite their exceptional anti-inflammatory properties, the use of systemic glucocorticoids (GCs) for the treatment of rheumatoid arthritis (RA) remains controversial due to the potential side effects, particularly their role in elevating patients’ risk of cardiovascular (CV) events. A po
03 Jan 2024
thumb

Dr. So, Ho

Assistant Professor,
Division of Rheumatology,
Department of Medicine and Therapeutics,
Faculty of Medicine,
The Chinese University of Hong Kong

Ann Rheum Dis. 2023.

So H, Lam TO (co-first author), Meng H, Lam SHM, Tam LS. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2023;82(11):1387-1393.
Case review View All

A local case sharing: Romosozumab as a novel bone-forming alternative in postmenopausal women with osteoporosis

​ It is often a challenge to manage serious but asymptomatic illnesses, and osteoporosis is one of them.1,2 Osteoporosis, a metabolic bone disease characterized by low bone density and increased risks of fragility fractures, is common among Hong Kong population aged ≥50 years, with its prevalence m
13 Jan 2022
thumb

Dr. Tse, Yun-Tin Paul

Specialist in Orthopaedics & Traumatology
News & perspective View All

The expanding role of musculoskeletal ultrasound in gout diagnosis and management in Hong Kong

Musculoskeletal ultrasound (MSUS) has emerged as an invaluable diagnostic and prognostic tool in rheumatology, often complementing clinical evidence to bolster its role in managing patients with rheumatoid arthritis (RA) or juvenile idiopathic arthritis (JIA).1-3 During the 28th Hong Kong Medical Fo
19 Sep 2024

The expanding role of musculoskeletal ultrasound in gout diagnosis and management in Hong Kong

MSUS has emerged as an invaluable diagnostic and prognostic tool in rheumatology, often complementing clinical evidence to bolster its role in managing patients with rheumatoid arthritis or juvenile idiopathic arthritis. During the 28th Hong Kong Medical Forum, Dr. Ho, Tze-Kwan Carmen shared her insights on the implementation of MSUS and the interpretation of its results in gout management.
16 Jul 2024
Infographics View All
RHEUMATOLOGY

Decoding SSc-ILD in Hong Kong: Epidemiological Insights and Predictive Biomarkers

22 Sep 2025